Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
151 hedge funds and large institutions have $509M invested in Surmodics in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 49 reducing their positions, and 25 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 49
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 86.87% → 86.87% (-0%)
6% less funds holding
Funds holding: 161 → 151 (-10)
8% less capital invested
Capital invested by funds: $554M → $509M (-$44.9M)
27% less call options, than puts
Call options by funds: $509K | Put options by funds: $700K
40% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$5.88M |
| 2 |
TA
Teachers Advisors
New York
|
+$4.52M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.94M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.8M |
| 5 |
Goldman Sachs
New York
|
+$1.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.28M |
| 2 |
CM
Castleark Management
Chicago,
Illinois
|
-$2.94M |
| 3 |
Morgan Stanley
New York
|
-$2.38M |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$2.35M |
| 5 |
Renaissance Technologies
New York
|
-$2.17M |
SRDX Hedge Fund Activity: Q1 2019 in Review
151 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2019, worth a combined $509M — down 8.1% from $554M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of SRDX and 15 opened new positions — a net loss of 10 holders — while 49 trimmed existing stakes and 58 added.
The largest buyer was Janus Henderson Group, adding an estimated $5.88M. The largest seller was Millennium Management, cutting an estimated $3.28M.
- 151 institutional investors held Surmodics (SRDX) as of Q1 2019, down from 161 in Q4 2018.
- Funds reported $509M of Surmodics stock for Q1 2019, down 8.1% quarter-over-quarter.
- 15 funds opened new Surmodics positions in Q1 2019 and 25 closed out, a net change of -10 holders.
- The largest Surmodics buyer in Q1 2019 was Janus Henderson Group, an estimated $5.88M added.
- The largest Surmodics seller in Q1 2019 was Millennium Management, an estimated $3.28M sold.
Based on aggregated 13F filings for Q1 2019.